Europe IVD Market

Europe IVD Market Size by Product Type (Reagents, Software, Instruments, Services and Others), Technology (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology, Coagulation and Hemostasis, Microbiology, and Others), Application (Infectious Diseases, Cardiac Diseases, Nephrological Diseases, Cancer, Infectious Diseases, Drug Testing, HIV, Immune System Disorders, Gastrointestinal Diseases, and Others), End User (Standalone Laboratories, Research and Academic Institutions, Medical Institutions, Hospitals, Point-Of-Care, and Others), Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13511
  • Published Date: Jun, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The Europe IVD market was valued at USD 10 billion in 2022 and grew at a CAGR of 6% from 2023 to 2032. The market is expected to reach USD 17.90 billion by 2032. The increasing incidence of infectious diseases will drive the growth of the Europe IVD market.

Market Introduction:

IVD stands for in vitro diagnostics. It is a testing method that identifies diseases, disorders, and infections. In vitro translates to "in glass," which comes from the fact that these tests are usually carried out in test tubes. Human fluids like blood, tissues, and proteins are collected as samples. IVD is used to test the presence of certain components, like bacteria and viruses, in these samples to determine a person's health. They are highly effective in diagnosing diseases or other disorders, which then helps in treating, preventing, or curing the said diseases/disorders. It is the first step towards creating a treatment plan suited for the diagnosis. The IVD medical devices are developed, produced, and packaged in a way that minimises the danger caused by contaminants and residues engaged in their transit, storage, and use. IVDs have a wide variety of applications and are known to offer Fast Results with their reduced downtime. It allows Multiple tests with variation testing for each of those tests to detect different chemicals. They are cost-effective and less time-consuming. They are reliable as they have a low tendency to deliver false results.

Europe IVD Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • February 2022: For there, AlzoSure Predict predictive blood test for the early prediction of Alzheimer's disease, Diadem Srl announced CE IVD certification. With the help of the CE IVD (European Conformity In-Vitro Diagnostic Medical Devices) certification, Diadem can market the AlzoSure Predict test in the U.K. and the other 27 E.U. member states. Additionally, it helps the rest of the world's markets develop. A biomarker blood test called AlzoSure Predict can accurately predict whether people over 50 who show indicators of cognitive impairment will or won't develop Alzheimer's disease up to six years before overt symptoms appear.
  • August 2022: In Europe, Predicine has made available its CE-certified PredicineCARE for genetic profiling in blood and urine. A focused next-generation sequencing experiment called the cell-free DNA assay is used to identify single nucleotide variants, insertions and deletions, DNA reorganisations, and copy number abnormalities in cancer patients. The assay has been utilised in patient testing, clinical studies, and the creation of companion diagnostics. PredicineCARE's introduction as the first CE-IVD recognised product is a key milestone that is in line with the company's objectives of offering a molecular testing solution that is both affordable and widely available in the European market.
  • June 2022 - To increase patient safety, Switzerland's new legislation on in vitro diagnostic medical devices (IvDO) went into effect. It tightened up the standards for conformity evaluation and post-market surveillance. IvDO was put into operation in Switzerland on the same day the European Union's In Vitro Diagnostic Regulation (IVDR) went into effect.

Market Dynamics:

Drivers

The increasing incidence of chronic and infectious diseasesthe climate change crisis has led to melting permafrost, increasing the risk of endemic diseases like smallpox and influenza returning with new and more deadly strains. The covid-19 pandemic has highlighted the risks and losses brought on by an infectious disease. The likelihood of viral pandemics in the future is high. Furthermore, lifestyle and environmental changes have increased the incidence of chronic diseases and disorders. The growing geriatric population is contributing to the rising patient pool. Therefore, the increasing incidence of chronic and infectious diseases will drive the market's growth.

Restraints:

The lack of skilled personnel the covid-19 pandemic highlighted the lack of human resources in laboratories across Europe to perform diagnostics, monitoring, contact tracing and control of the virus. The facilities were overwhelmed by the number of infections, resulting in a lag in identifying new strains, leading to late policy interventions to prevent its spread. Additionally, IVDs are a sophisticated piece of medical devices that can only be operated by qualified and trained personnel. The need to have highly skilled people is imperative, considering that the laboratories deal in deadly infectious daily, which can lead to contamination and leakage if not handled properly. Therefore, the lack of skilled personnel will hamper the market's growth.

Opportunities:

The technological advancements the increasing incidence of cancer and autoimmune diseases has pushed the stakeholders towards developing better diagnostics, drug, therapies and technologies that can prevent deaths. The market players are investing heavily towards developing advanced IVD technologies, software, hardware and services to improve results, making them more reliable, detailed and accurate. The increasing adoption of personalized medicine, gene therapy or stem cells has increased the demand for better diagnostics. Therefore, technological advancements will offer lucrative opportunities for the market's growth in the future.

Product type Segment Analysis

The product type segment is divided into reagents, software, instruments, services and others. The reagents segment dominated the market, with a market share of around 40% in 2022. a reagent is a mixture of compounds used in a laboratory or, occasionally, an industrial context. Reagents are diluted solutions of very particular biological or chemical compounds that can interact with the target compounds in the samples. It tests samples, mixtures and other compounds in laboratory testing. They can also be used to make or measure compounds. IVD reagents are used for patient diagnosis, monitoring, and treatment. They can be manufactured easily and are accessible compared to other product types. They are compatible with almost all laboratory instruments which widen their scope of application.

Technology Segment Analysis

The technology segment is divided into clinical chemistry, immunoassays, molecular diagnostics, hematology, coagulation and hemostasis, microbiology, and others. The molecular diagnostics segment dominated the market, with a market share of around 34% in 2022. Molecular diagnostics is the method of determining disease by examining molecules in a tissue or fluid. It speeds up the process of detection, diagnosis, subclassification, and prognosis, thereby offering effective and precise treatment solutions. It is the gateway to personalized and targeted medicine. Molecular techniques reduce the likelihood of false positive test findings. Molecular approaches typically offer faster turnaround times, saving time, money and patients' lives. Molecular diagnostics are cost-effective because they provide greater diagnostic accuracy for a wide spectrum of pathogens while utilising a limited consumable palette.

Application Segment Analysis

The application segment is divided into infectious diseases, cardiac diseases, nephrological diseases, cancer, infectious diseases, drug testing, HIV, immune system disorders, gastrointestinal diseases, and others. The infectious diseases segment dominated the market, with a market share of around 33% in 2022. organisms like bacteria, viruses, fungi, or parasites bring on infectious diseases. Common colds, influenza, COVID-19, and stomach flu are common infectious diseases. IVD tests are used to determine whether a person is infected with a virus, bacteria or fungus and then to use the diagnosis to treat the patient accordingly. IVD delivers fast results, which makes them popular during emergencies, just as witnessed in the covid-19 pandemic. The acceptance rate of IVD tests in hospitals has increased as their use becomes easier. The covid-19 pandemic offered a need fillip for the use of IVD. It also accelerated the advancement and development of better IVD, contributing to the segment's growth.

End-user Segment Analysis

The end-user segment is divided into standalone laboratories, research and academic institutions, medical institutions, hospitals, point-of-care, and others. The hospitals' diseases segment dominated the market, with a market share of around 43% in 2022. The hospitals in Europe are well-developed and equipped with the necessary infrastructure and personnel to perform IVD. The fiscal policies ensuring universal care for all also contribute to the segment’s growth. The fiscal authorities also provide the necessary funding to ramp up the segment's development. The research and development also lead to the segment's growth in the forecast period.

Some of the Key Market Players:
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Siemens AG
  • Qiagen N.V.
  • Hoffmann-La Roche AG
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Becton, Dickinson and Company
  • Abbott Laboratories

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 10 Billion
Market size value in 2032 USD 17.90 Billion
CAGR (2023 to 2032) 6%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Segments Product Type, Technology, Application and End User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the Europe IVD market was valued at USD 10 billion in 2022 to USD 17.90 billion by 2032.

Europe IVD market is growing at a CAGR of 6% during the forecast period 2023-2032.

The market's growth will be influenced by the increasing incidence of chronic and infectious diseases.

The lack of skilled personnel could hamper the market growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Technology
          4.3.3. Market Attractiveness Analysis by Application
          4.3.4. Market Attractiveness Analysis by End User
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing incidence of chronic and infectious diseases
    5.3. Restraints
          5.3.1. The lack of skilled personnel
    5.4. Opportunities
          5.4.1. The technological advancements
    5.5. Challenges
          5.5.1. The stringent regulatory framework

6. Europe IVD Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Reagents
    6.3. Software
    6.4. Instruments
    6.5. Services
    6.6. Others

7. Europe IVD Market Analysis and Forecast, By Technology
    7.1. Segment Overview
    7.2. Clinical Chemistry
    7.3. Immunoassays
    7.4. Molecular Diagnostics
    7.5. Hematology
    7.6. Coagulation and Hemostasis
    7.7. Microbiology
    7.8. Others

8. Europe IVD Market Analysis and Forecast, By Application
    8.1. Segment Overview
    8.2. Infectious Diseases
    8.3. Cardiac Diseases
    8.4. Nephrological Diseases
    8.5. Cancer
    8.6. Infectious Diseases
    8.7. Drug Testing
    8.8. HIV
    8.9. Immune System Disorders
    8.10. Gastrointestinal Diseases
    8.11. Others

9. Europe IVD Market Analysis and Forecast, By Product Type
    9.1. Segment Overview
    9.2. Standalone Laboratories
    9.3. Research and Academic Institutions
    9.4. Medical Institutions
    9.5. Hospitals
    9.6. Point-Of-Care
    9.7. Others

10. Europe IVD Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the Europe IVD Market
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Thermo Fisher Scientific
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Sysmex Corporation
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Siemens AG
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Qiagen N.V.
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Hoffmann-La Roche AG
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Danaher Corporation
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Bio-Rad Laboratories, Inc.
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. Biomérieux SA
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Becton, Dickinson and Company
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Abbott Laboratories
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis

List of Table

1. Europe IVD Market, By Product Type, 2019-2032 (USD Billion) 

2. Europe Reagents IVD Market, By Region, 2019-2032 (USD Billion) 

3. Europe Software IVD Market, By Region, 2019-2032 (USD Billion) 

4. Europe Instruments IVD Market, By Region, 2019-2032 (USD Billion) 

5. Europe Services IVD Market, By Region, 2019-2032 (USD Billion) 

6. Europe Others IVD Market, By Region, 2019-2032 (USD Billion) 

7. Europe IVD Market, By Technology, 2019-2032 (USD Billion) 

8. Europe Clinical Chemistry IVD Market, By Region, 2019-2032 (USD Billion) 

9. Europe Immunoassays IVD Market, By Region, 2019-2032 (USD Billion) 

10. Europe Molecular Diagnostics IVD Market, By Region, 2019-2032 (USD Billion) 

11. Europe Hematology IVD Market, By Region, 2019-2032 (USD Billion) 

12. Europe Coagulation and Hemostasis IVD Market, By Region, 2019-2032 (USD Billion) 

13. Europe Microbiology IVD Market, By Region, 2019-2032 (USD Billion) 

14. Europe Others IVD Market, By Region, 2019-2032 (USD Billion) 

15. Europe IVD Market, By Application, 2019-2032 (USD Billion) 

16. Europe Infectious Diseases IVD Market, By Region, 2019-2032 (USD Billion) 

17. Europe Cardiac Diseases IVD Market, By Region, 2019-2032 (USD Billion) 

18. Europe Nephrological Diseases IVD Market, By Region, 2019-2032 (USD Billion) 

19. Europe Cancer IVD Market, By Region, 2019-2032 (USD Billion) 

20. Europe Infectious Diseases IVD Market, By Region, 2019-2032 (USD Billion) 

21. Europe Drug Testing IVD Market, By Region, 2019-2032 (USD Billion) 

22. Europe HIV IVD Market, By Region, 2019-2032 (USD Billion) 

23. Europe Immune System Disorders IVD Market, By Region, 2019-2032 (USD Billion) 

24. Europe Gastrointestinal Diseases IVD Market, By Region, 2019-2032 (USD Billion) 

25. Europe Others IVD Market, By Region, 2019-2032 (USD Billion) 

26. Europe IVD Market, By End User, 2019-2032 (USD Billion) 

27. Europe Standalone Laboratories IVD Market, By Region, 2019-2032 (USD Billion) 

28. Europe Research and Academic Institutions IVD Market, By Region, 2019-2032 (USD Billion) 

29. Europe Medical Institutions IVD Market, By Region, 2019-2032 (USD Billion) 

30. Europe Hospitals IVD Market, By Region, 2019-2032 (USD Billion) 

31. Europe Point-Of-Care IVD Market, By Region, 2019-2032 (USD Billion) 

32. Europe Others IVD Market, By Region, 2019-2032 (USD Billion) 

List of Figures 

1. Europe IVD Market Segmentation

2. IVD Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Europe IVD Market Attractiveness Analysis by Product Type

9. Europe IVD Market Attractiveness Analysis by Technology

10. Europe IVD Market Attractiveness Analysis by Application

11. Europe IVD Market Attractiveness Analysis by End User

12. Europe IVD Market: Dynamics

13. Europe IVD Market Share by Product Type (2022 & 2032)

14. Europe IVD Market Share by Technology (2022 & 2032)

15. Europe IVD Market Share by Application (2022 & 2032)

16. Europe IVD Market Share by End User (2022 & 2032)

17. Europe IVD Market Share by Company (2022)

This study forecasts revenue from 2019 to 2032. The Brainy Insights has segmented the Europe IVD market based on below mentioned segments:

Europe IVD Market by Product Type:

  • Reagents
  • Software
  • Instruments
  • Services
  • Others

Europe IVD Market by Technology:

  • Clinical Chemistry
  • Immunoassays
  • Molecular Diagnostics
  • Hematology
  • Coagulation and Hemostasis
  • Microbiology
  • Others

Europe IVD Market by Application:

  • Infectious Diseases
  • Cardiac Diseases
  • Nephrological Diseases
  • Cancer
  • Infectious Diseases
  • Drug Testing
  • HIV
  • Immune System Disorders
  • Gastrointestinal Diseases
  • Others

Europe IVD Market by End User:

  • Standalone Laboratories
  • Research and Academic Institutions
  • Medical Institutions
  • Hospitals
  • Point-Of-Care
  • Others

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date